Compare TechnipFMC plc Ordinary Share (FTI) vs Iovance Biotherapeutics Inc. Common Stock (IOVA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TechnipFMC plc Ordinary Share vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? TechnipFMC plc Ordinary Share trades at $70.35 (market cap $27.31B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.19 (market cap $6.04B). The key difference: TechnipFMC plc Ordinary Share is far larger — about 4.5× Iovance Biotherapeutics Inc. Common Stock's market cap, and TechnipFMC plc Ordinary Share pays a 0.29% dividend while Iovance Biotherapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold TechnipFMC plc Ordinary Share for 0 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| FTI | IOVA | |
|---|---|---|
Market Cap | $27.31B | $6.04B |
Volume | 2,496,410 | 14,805,993 |
Sector | Energy | Health |
52-Week High | $80.08 | $14.82 |
52-Week Low | $35.57 | $1.81 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $27.56B | $5.97B |
Dividend Yield | 0.29% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TechnipFMC plc Ordinary Share
TechnipFMC is an energy technology company providing subsea systems, surface technologies, and related services across the life of oil and gas fields. Its offerings include equipment, controls, installation support, and digital tools for offshore and onshore projects.
Read more on FTI →About Iovance Biotherapeutics Inc. Common Stock
Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →
